INFIRMARY DRIVE MEDICAL GROUP
INFIRMARY DRIVE MED GROUP, THE CONSULTING ROOMS, ALNWICK, NORTHUMBERLAND
CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 44 | 55 | 80.0% | |
| CKD 4 | 2008 | 45 | 46 | 97.8% | |
| CKD 5 | 2009 | 20 | 21 | 95.2% | |
| CKD 5 | 2010 | 51 | 56 | 91.1% | |
| CKD 5 | 2011 | 59 | 62 | 95.2% | |
| CKD 5 | 2012 | 59 | 66 | 89.4% | |
| CKD 5 | 2013 | 52 | 64 | 81.2% | |
| CKD003 | 2014 | 49 | 53 | 92.5% | |
| CKD003 | 2015 | 42 | 44 | 95.5% | |
| NM84 | 2016 | 40 | 58 | 69.0% | |
| NM84 | 2017 | 37 | 51 | 72.5% |
